4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0001209191-22-020682
Chief Executive Officer bought 5,000 shares at $2.15 ($10,750)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schambye Hans T. Chief Executive Officer | 2022-03-22 | Purchase | +5,000 | $2.15 | $10,750 | 52,428 | D |
| Open-market purchases · 5,000 sh · avg $2.15 · $10,750 | |||||||
Loading xslF345X03/doc4.xml…